SCHEMBL20940200

SCHEMBL20940200

Cc1cc2c(Cl)cccc2[nH]c1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.65
BRD4 O60885 1/20 0.53
GRIN2D O15399 4/20 0.52
GRIN3B O60391 4/20 0.52
GRIN1 Q05586 4/20 0.52
GRIN2A Q12879 4/20 0.52
GRIN2B Q13224 4/20 0.52
GRIN2C Q14957 4/20 0.52
GRIN3A Q8TCU5 4/20 0.52
DDO Q99489 3/20 0.51
ATAD2 Q6PL18 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
GRIA1 P42261 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20247282 0.83 DAO (0.71) DAOBRD4GRIN2DGRIN3BGRIN1
SCHEMBL30667289 0.83 DAO (0.71) DAOBRD4GRIN2DGRIN3BGRIN1
SCHEMBL22571313 0.79 DAO (0.61) DAOGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL16767849 0.79 DAO (1.00) DAOGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL31139816 0.79 DAO (0.65) DAOBRD4GRIN2DGRIN3BGRIN1
SCHEMBL29471220 0.79 BRD4 (0.53) DAOBRD4GRIN2DGRIN3BGRIN1
SCHEMBL26551030 0.79 BRD4 (0.53) DAOBRD4GRIN2DGRIN3BGRIN1
SCHEMBL12970533 0.79 DAO (0.65) DAOBRD4GRIN2DGRIN3BGRIN1
SCHEMBL20940121 0.78 DAO (0.59) DAOGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL30716611 0.78 DAO (0.59) DAOGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753400-B2 D-amino acid oxidase inhibitors and therapeutic uses thereof SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2023-09-12 US disclosed
WO-2019076329-A9 D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF TSAI GUOCHUAN EMIL (CN) 2019-08-15 WO disclosed
WO-2019076329-A1 D-AMINO ACID OXIDASE INHIBITORS AND THERAPEUTIC USES THEREOF TSAI GUOCHUAN EMIL (CN) 2019-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753400-B2 D-amino acid oxidase inhibitors and therapeutic uses thereof DAO, DDO, DDC DAO 1/4885BRD4 3000/4885GRIN2D 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.